Editorial: Chronic Liver Disease: New Targets and New Mechanisms
Front Mol Biosci
.
2022 Jul 18:9:963630.
doi: 10.3389/fmolb.2022.963630.
eCollection 2022.
Authors
Yanting Ye
1
,
Hua Wang
2
,
Jinhang Gao
1
,
Enis Kostallari
3
Affiliations
1
Lab of Gastroenterology and Hepatology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
2
Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
3
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
PMID:
35923468
PMCID:
PMC9341181
DOI:
10.3389/fmolb.2022.963630
No abstract available
Keywords:
ALD; NASH; biomarkers; chronic liver disease; cirrhosis; hepatitis; therapeutic targets.
Publication types
Editorial